BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15196699)

  • 21. Molecular mechanisms of alcoholic fatty liver: role of peroxisome proliferator-activated receptor alpha.
    Crabb DW; Galli A; Fischer M; You M
    Alcohol; 2004 Aug; 34(1):35-8. PubMed ID: 15670663
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation of peroxisome proliferator-activated receptor alpha in rat spinal cord after peripheral noxious stimulation.
    Benani A; Heurtaux T; Netter P; Minn A
    Neurosci Lett; 2004 Oct; 369(1):59-63. PubMed ID: 15380308
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fine metabolic regulation in ruminants via nutrient-gene interactions: saturated long-chain fatty acids increase expression of genes involved in lipid metabolism and immune response partly through PPAR-α activation.
    Bionaz M; Thering BJ; Loor JJ
    Br J Nutr; 2012 Jan; 107(2):179-91. PubMed ID: 21729373
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
    Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
    Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Euchresta horsfieldii Benn. activates peroxisome proliferator-activated receptor α and regulates expression of genes involved in fatty acid metabolism in human HepG2 cells.
    Kim JH; Kim D; Kim J; Hwang JK
    J Ethnopharmacol; 2011 Jan; 133(1):244-7. PubMed ID: 20920566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular characterization of novel and selective peroxisome proliferator-activated receptor alpha agonists with robust hypolipidemic activity in vivo.
    Kane CD; Stevens KA; Fischer JE; Haghpassand M; Royer LJ; Aldinger C; Landschulz KT; Zagouras P; Bagley SW; Hada W; Dullea R; Hayward CM; Francone OL
    Mol Pharmacol; 2009 Feb; 75(2):296-306. PubMed ID: 18971326
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
    Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
    Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Influence of DMBA-induced mammary cancer on the liver CPT I, mit HMG-CoA synthase and PPARalpha mRNA expression in rats fed a low or high corn oil diet.
    Moral R; Solanas M; Manzanares EM; Haro D; Escrich E
    Int J Mol Med; 2004 Aug; 14(2):283-7. PubMed ID: 15254779
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of peroxisomal proliferator activated receptors alpha and delta in skeletal muscle in response to changes in diet and exercise.
    Kannisto K; Chibalin A; Glinghammar B; Zierath JR; Hamsten A; Ehrenborg E
    Int J Mol Med; 2006 Jan; 17(1):45-52. PubMed ID: 16328010
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Interleukin-1 receptor antagonist is a direct target gene of PPARalpha in liver.
    Stienstra R; Mandard S; Tan NS; Wahli W; Trautwein C; Richardson TA; Lichtenauer-Kaligis E; Kersten S; Müller M
    J Hepatol; 2007 May; 46(5):869-77. PubMed ID: 17321000
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The transcriptional coactivator peroxisome proliferator activated receptor (PPAR)gamma coactivator-1 alpha and the nuclear receptor PPAR alpha control the expression of glycerol kinase and metabolism genes independently of PPAR gamma activation in human white adipocytes.
    Mazzucotelli A; Viguerie N; Tiraby C; Annicotte JS; Mairal A; Klimcakova E; Lepin E; Delmar P; Dejean S; Tavernier G; Lefort C; Hidalgo J; Pineau T; Fajas L; Clément K; Langin D
    Diabetes; 2007 Oct; 56(10):2467-75. PubMed ID: 17646210
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatty acid oxidation inhibition with PPARalpha activation (FOXIB/PPARalpha) for normalizing gene expression in heart failure?
    Rupp H; Rupp TP; Maisch B
    Cardiovasc Res; 2005 Jun; 66(3):423-6. PubMed ID: 15914105
    [No Abstract]   [Full Text] [Related]  

  • 33. Differential regulation of fatty acid elongation enzymes in brown adipocytes implies a unique role for Elovl3 during increased fatty acid oxidation.
    Jakobsson A; Jörgensen JA; Jacobsson A
    Am J Physiol Endocrinol Metab; 2005 Oct; 289(4):E517-26. PubMed ID: 15855229
    [TBL] [Abstract][Full Text] [Related]  

  • 34. AMPK activation increases fatty acid oxidation in skeletal muscle by activating PPARalpha and PGC-1.
    Lee WJ; Kim M; Park HS; Kim HS; Jeon MJ; Oh KS; Koh EH; Won JC; Kim MS; Oh GT; Yoon M; Lee KU; Park JY
    Biochem Biophys Res Commun; 2006 Feb; 340(1):291-5. PubMed ID: 16364253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in liver PPARalpha mRNA expression in response to two levels of high-safflower-oil diets correlate with changes in adiposity and serum leptin in rats and mice.
    Hsu SC; Huang CJ
    J Nutr Biochem; 2007 Feb; 18(2):86-96. PubMed ID: 16713235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The protein kinase C signaling pathway regulates a molecular switch between transactivation and transrepression activity of the peroxisome proliferator-activated receptor alpha.
    Blanquart C; Mansouri R; Paumelle R; Fruchart JC; Staels B; Glineur C
    Mol Endocrinol; 2004 Aug; 18(8):1906-18. PubMed ID: 15131257
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty acid chain length and saturation influences PPARα transcriptional activation and repression in HepG2 cells.
    Popeijus HE; van Otterdijk SD; van der Krieken SE; Konings M; Serbonij K; Plat J; Mensink RP
    Mol Nutr Food Res; 2014 Dec; 58(12):2342-9. PubMed ID: 25255786
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Influence of Genistein on Hepatic Lipid Metabolism in an In Vitro Model of Hepatic Steatosis.
    Seidemann L; Krüger A; Kegel-Hübner V; Seehofer D; Damm G
    Molecules; 2021 Feb; 26(4):. PubMed ID: 33671486
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discovery of gemfibrozil analogues that activate PPARα and enhance the expression of gene CPT1A involved in fatty acids catabolism.
    De Filippis B; Giancristofaro A; Ammazzalorso A; D'Angelo A; Fantacuzzi M; Giampietro L; Maccallini C; Petruzzelli M; Amoroso R
    Eur J Med Chem; 2011 Oct; 46(10):5218-24. PubMed ID: 21889235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.